Sports Performance Testing & Programs | NYU Langone Health
NYU Langone's Sports Performance Center offers sports performance testing and programs that can help maximize your athletic ability.
Sports Pulmonology Services | NYU Langone Health
At NYU Langone, our specialists in pulmonary medicine care for athletes with conditions affecting the lungs.
Sports Rehabilitation Services | NYU Langone Health
NYU Langone sports rehabilitation experts provide rehabilitation services to help athletes and active people return to sports safely.
Sports Rheumatology Services | NYU Langone Health
NYU Langone rheumatologists care for athletes of all ages with inflammatory and immune system disorders.
Staging & Grading Prostate Cancer | NYU Langone Health
Staging and grading prostate cancer help NYU Langone doctors diagnose and treat prostate cancer, while helping patients better understand their outlook.
Standard Charges
NYU Langone’s list of standard charges for items and services do not reflect or represent the actual out-of-pocket cost a patient pays for these services.
Staphylococcal Infections | NYU Langone Health
NYU Langone doctors diagnose and manage staphylococcus, or staph, infections and take steps to prevent a recurrence.
Staten Island Locations | NYU Langone Health
See all NYU Langone locations on Staten Island and find locations in your neighborhood.
STATINS USE IN INRACEREBRAL HEMORRHAGE PATIENTS (SATURN)
This is a multi-center, pragmatic, prospective, randomized, open-label, and blinded end-point assessment (PROBE) clinical trial. A total of 1,456 patients presenting within 7 days of a spontaneous lobar ICH while taking statins will be randomized to one of two treatment strategies: discontinuation vs. continuation (restarting) of statin therapy (using the same agent and dose that they were using at ICH onset). Randomization will take into account: clinical site, statin dose and indication (primary vs. secondary prevention), current use and intent-to-use oral anticoagulants (OAC) and/or antiplatelets in the long-term post-ICH, and severity of ICH upon presentation as assessed by baseline ICH volume.Participating subjects will undergo baseline testing for APOE genotype and will be followed for 24 months to assess for the occurrence of recurrent symptomatic ICH or MACCE during the follow-up period.
Stem Cell Transplantation for Acute Lymphoblastic Leukemia | NYU Langone Health
NYU Langone doctors may recommend a stem cell transplant to treat acute lymphoblastic leukemia that is likely to recur.